IRIS Accounts Production v24.3.2.46 07096400 director 1.7.23 30.6.24 30.6.24 false true false false true false Ordinary 1.00000 A & B Ordinary 1.00000 C & D Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh070964002023-06-30070964002024-06-30070964002023-07-012024-06-30070964002022-06-30070964002022-07-012023-06-30070964002023-06-3007096400ns15:EnglandWales2023-07-012024-06-3007096400ns14:PoundSterling2023-07-012024-06-3007096400ns10:Director12023-07-012024-06-3007096400ns10:PrivateLimitedCompanyLtd2023-07-012024-06-3007096400ns10:SmallEntities2023-07-012024-06-3007096400ns10:AuditExempt-NoAccountantsReport2023-07-012024-06-3007096400ns10:SmallCompaniesRegimeForDirectorsReport2023-07-012024-06-3007096400ns10:SmallCompaniesRegimeForAccounts2023-07-012024-06-3007096400ns10:AbridgedAccounts2023-07-012024-06-3007096400ns10:OrdinaryShareClass12023-07-012024-06-3007096400ns10:OrdinaryShareClass22023-07-012024-06-3007096400ns10:OrdinaryShareClass32023-07-012024-06-3007096400ns10:CompanySecretary12023-07-012024-06-3007096400ns10:RegisteredOffice2023-07-012024-06-3007096400ns5:CurrentFinancialInstruments2024-06-3007096400ns5:CurrentFinancialInstruments2023-06-3007096400ns5:Non-currentFinancialInstruments2024-06-3007096400ns5:Non-currentFinancialInstruments2023-06-3007096400ns5:ShareCapital2024-06-3007096400ns5:ShareCapital2023-06-3007096400ns5:RetainedEarningsAccumulatedLosses2024-06-3007096400ns5:RetainedEarningsAccumulatedLosses2023-06-3007096400ns5:ShortLeaseholdAssetsns5:LandBuildings2023-07-012024-06-3007096400ns5:PlantMachinery2023-07-012024-06-3007096400ns5:FurnitureFittings2023-07-012024-06-3007096400ns5:ComputerEquipment2023-07-012024-06-3007096400ns5:DeferredTaxation2023-06-3007096400ns5:DeferredTaxation2023-07-012024-06-3007096400ns5:DeferredTaxation2024-06-3007096400ns10:OrdinaryShareClass12024-06-3007096400ns10:OrdinaryShareClass22024-06-3007096400ns10:OrdinaryShareClass32024-06-30070964001ns10:Director12023-06-30070964001ns10:Director12022-06-30070964001ns10:Director12023-07-012024-06-30070964001ns10:Director12022-07-012023-06-30070964001ns10:Director12024-06-30070964001ns10:Director12023-06-30
REGISTERED NUMBER: 07096400 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 June 2024

for

Aesthetic Health Ltd

Aesthetic Health Ltd (Registered number: 07096400)






Contents of the Financial Statements
for the Year Ended 30 June 2024




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


Aesthetic Health Ltd

Company Information
for the Year Ended 30 June 2024







DIRECTOR: Dr J Sevi





SECRETARY: Mr A Sevi





REGISTERED OFFICE: 305 Harrogate Road
Leeds
LS17 6PA





REGISTERED NUMBER: 07096400 (England and Wales)





ACCOUNTANTS: Wild & Co Chartered Accountants
Windsor House
Cornwall Road
Harrogate
HG1 2PW

Aesthetic Health Ltd (Registered number: 07096400)

Abridged Balance Sheet
30 June 2024

30.6.24 30.6.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 97,680 58,068

CURRENT ASSETS
Stocks 52,320 72,114
Debtors 24,724 53,776
Cash at bank 222,534 152,775
299,578 278,665
CREDITORS
Amounts falling due within one year 99,874 80,255
NET CURRENT ASSETS 199,704 198,410
TOTAL ASSETS LESS CURRENT
LIABILITIES

297,384

256,478

CREDITORS
Amounts falling due after more than one
year

(112,125

)

(90,000

)

PROVISIONS FOR LIABILITIES 6 (22,932 ) (9,408 )
NET ASSETS 162,327 157,070

CAPITAL AND RESERVES
Called up share capital 7 120 120
Retained earnings 162,207 156,950
SHAREHOLDERS' FUNDS 162,327 157,070

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Aesthetic Health Ltd (Registered number: 07096400)

Abridged Balance Sheet - continued
30 June 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 30 June 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 11 February 2025 and were signed by:





Dr J Sevi - Director


Aesthetic Health Ltd (Registered number: 07096400)

Notes to the Financial Statements
for the Year Ended 30 June 2024

1. STATUTORY INFORMATION

Aesthetic Health Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Short leasehold - Straight line over 4 years
Plant and machinery - 20% on cost
Fixtures and fittings - Straight line over 4 years
Computer equipment - Straight line over 4 years

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development
Expenditure on research and development is written off in the year in which it is incurred.


Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Aesthetic Health Ltd (Registered number: 07096400)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2024

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 14 (2023 - 15 ) .

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 July 2023 263,276
Additions 88,380
At 30 June 2024 351,656
DEPRECIATION
At 1 July 2023 205,208
Charge for year 48,768
At 30 June 2024 253,976
NET BOOK VALUE
At 30 June 2024 97,680
At 30 June 2023 58,068

5. SECURED DEBTS

The following secured debts are included within creditors:

30.6.24 30.6.23
£    £   
Bank Loan 45,612 52,091

Loans of £45,612 (FY23 - £52,091) are secured by a fixed and floating charge over the assets of the company.

6. PROVISIONS FOR LIABILITIES
30.6.24 30.6.23
£    £   
Deferred tax 22,932 9,408

Deferred
tax
£   
Balance at 1 July 2023 9,408
Provided during year 13,524
Balance at 30 June 2024 22,932

Aesthetic Health Ltd (Registered number: 07096400)

Notes to the Financial Statements - continued
for the Year Ended 30 June 2024

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.6.24 30.6.23
value: £    £   
100 Ordinary £1 100 100
10 A & B Ordinary £1 10 10
10 C & D Ordinary £1 10 10
120 120

8. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 June 2024 and 30 June 2023:

30.6.24 30.6.23
£    £   
Dr J Sevi
Balance outstanding at start of year - 7,474
Amounts advanced - (7,936 )
Amounts repaid - 462
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - -